Items where authors include "Walton, Matthew"

Article

Corbett, Mark orcid.org/0000-0002-5937-1493, Umemneku-Chikere, Chinyereugo orcid.org/0000-0003-4114-2227, Nevitt, Sarah orcid.org/0000-0001-9988-2709 et al. (7 more authors) (2026) Enzyme replacement therapy compared with best supportive care for the treatment of Pompe Disease:a systematic review and network meta-analysis. Health technology assessment (Winchester, England). pp. 1-58. ISSN 2046-4924

Walton, Matthew orcid.org/0000-0003-1932-3689, Llewellyn, Alexis orcid.org/0000-0003-4569-5136, Uphoff, Eleonora orcid.org/0000-0002-9759-2502 et al. (4 more authors) (2026) Artificial Intelligence technologies for assessing skin lesions for referral on the urgent suspected cancer pathway to detect benign lesions and reduce secondary care specialist appointments:early value assessment. Health technology assessment (Winchester, England). 3049943. ISSN 2046-4924

Simmonds, Mark orcid.org/0000-0002-1999-8515, Walton, Matthew orcid.org/0000-0003-1932-3689, Hodgson, Rob orcid.org/0000-0001-6962-2893 et al. (10 more authors) (2025) Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy:a systematic review and economic analysis. Health technology assessment (Winchester, England). pp. 1-16. ISSN 2046-4924

Simmonds, Mark orcid.org/0000-0002-1999-8515, Llewellyn, Alexis orcid.org/0000-0003-4569-5136, Walker, Ruth orcid.org/0000-0003-2765-7363 et al. (12 more authors) (2025) Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy:a systematic review and individual participant data meta-analysis. Health technology assessment (Winchester, England). pp. 89-164. ISSN 2046-4924

Walton, Matthew orcid.org/0000-0003-1932-3689, Bojke, Laura orcid.org/0000-0001-7921-9109, Simmonds, Mark orcid.org/0000-0002-1999-8515 et al. (10 more authors) (2024) Anti–Vascular Endothelial Growth Factor Drugs Compared With Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy:A Cost-Effectiveness Analysis. Value in Health. pp. 907-917. ISSN 1524-4733

Walton, Matthew orcid.org/0000-0003-1932-3689, Hodgson, Robert orcid.org/0000-0001-6962-2893, Eastwood, Alison orcid.org/0000-0003-1079-7781 et al. (7 more authors) (2022) Management of sudden onset severe headache patients presenting to the emergency Department:systematic review of diagnostic accuracy studies. Emergency Medicine Journal. pp. 818-825. ISSN 1472-0205

Beresford, Lucy, Murphy, Peter, Dias, Sofia orcid.org/0000-0002-2172-0221 et al. (7 more authors) (2022) Appraising the Costs of Genomic Testing for Histology-Independent Technologies:An Illustrative Example for NTRK Fusions. Value in Health. pp. 1133-1140. ISSN 1524-4733

Walton, Matthew orcid.org/0000-0003-1932-3689, Sharif, Sahar, Simmonds, Mark orcid.org/0000-0002-1999-8515 et al. (2 more authors) (2019) Tisagenlecleucel for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia in People Aged up to 25 Years:An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. pp. 1209-1217. ISSN 1179-2027

Peron, Mathilde, Llewellyn, Alexis orcid.org/0000-0003-4569-5136, Moe-Byrne, Thirimon orcid.org/0000-0002-2827-9715 et al. (5 more authors) (2018) Adjunctive colposcopy technologies for assessing suspected cervical abnormalities:systematic reviews and economic evaluation. Health technology assessment. pp. 1-260. ISSN 2046-4924

Hodgson, Robert orcid.org/0000-0001-6962-2893, Walton, Matthew orcid.org/0000-0003-1932-3689, Biswas, Mousumi orcid.org/0000-0001-6781-7400 et al. (2 more authors) (2017) Ustekinumab for Treating Moderately to Severely Active Crohn's Disease after Prior Therapy:An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. pp. 1-12. ISSN 1179-2027

Corbett, Mark orcid.org/0000-0002-5937-1493, Chehadah, Fadi, Biswas, Mousumi orcid.org/0000-0001-6781-7400 et al. (8 more authors) (2017) Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs:a systematic review and economic evaluation. Health technology assessment. pp. 1-326. ISSN 2046-4924